How many cancer patients use complementary and alternative medicine: a systematic review and metaanalysis.

PubWeight™: 2.43‹?› | Rank: Top 2%

🔗 View Article (PMID 22019489)

Published in Integr Cancer Ther on October 21, 2011

Authors

Markus Horneber1, Gerd Bueschel, Gabriele Dennert, Danuta Less, Erik Ritter, Marcel Zwahlen

Author Affiliations

1: Department of Internal Medicine, Division ofOncology/Hematology, Klinikum Nuernberg, Nuernberg, Germany. horneber@klinikum-nuernberg.de

Articles citing this

Clinical practice guidelines on the use of integrative therapies as supportive care in patients treated for breast cancer. J Natl Cancer Inst Monogr (2014) 2.13

Online survey of patients with breast cancer on complementary and alternative medicine. Breast Care (Basel) (2014) 1.07

Characteristics associated with the use of complementary health approaches among long-term cancer survivors. Support Care Cancer (2013) 1.03

Patients with advanced cancer and their usage of complementary and alternative medicine. J Cancer Res Clin Oncol (2013) 0.99

Therapeutic efficacy of traditional Chinese medicine, Shen-Mai San, in cancer patients undergoing chemotherapy or radiotherapy: study protocol for a randomized, double-blind, placebo-controlled trial. Trials (2012) 0.97

Integrative oncology for breast cancer patients: introduction of an expert-based model. BMC Cancer (2012) 0.96

Utilization of and Attitudes towards Traditional Chinese Medicine Therapies in a Chinese Cancer Hospital: A Survey of Patients and Physicians. Evid Based Complement Alternat Med (2012) 0.92

Integrative oncology: best of both worlds-theoretical, practical, and research issues. Evid Based Complement Alternat Med (2013) 0.91

A survey of complementary and alternative medicine use in cancer patients treated with radiotherapy in Thailand. Evid Based Complement Alternat Med (2012) 0.91

Complementary and Alternative Medicine Use among Norwegian Cancer Survivors: Gender-Specific Prevalence and Associations for Use. Evid Based Complement Alternat Med (2013) 0.91

Integrative oncology in Indian subcontinent: an overview. J Clin Diagn Res (2015) 0.88

Prayer-for-health and complementary alternative medicine use among Malaysian breast cancer patients during chemotherapy. BMC Complement Altern Med (2014) 0.87

The role of acupoint stimulation as an adjunct therapy for lung cancer: a systematic review and meta-analysis. BMC Complement Altern Med (2013) 0.85

A multisite, community oncology-based randomized trial of a brief educational intervention to increase communication regarding complementary and alternative medicine. Cancer (2013) 0.85

Perception of cancer patients of their disease, self-efficacy and locus of control and usage of complementary and alternative medicine. J Cancer Res Clin Oncol (2015) 0.85

Translation and adaptation of an international questionnaire to measure usage of complementary and alternative medicine (I-CAM-G). BMC Complement Altern Med (2012) 0.84

Any difference? Use of a CAM provider among cancer patients, coronary heart disease (CHD) patients and individuals with no cancer/CHD. BMC Complement Altern Med (2012) 0.84

Coping with physical and psychological symptoms: a qualitative study of advanced lung cancer patients and their family caregivers. Support Care Cancer (2014) 0.83

Intervention development for integration of conventional tobacco cessation interventions into routine CAM practice. BMC Complement Altern Med (2015) 0.83

Survey on the worldwide Chronic Myeloid Leukemia Advocates Network regarding complementary and alternative medicine. J Cancer Res Clin Oncol (2013) 0.83

MERGING conventional and complementary medicine in a clinic department - a theoretical model and practical recommendations. BMC Complement Altern Med (2015) 0.82

Complementary and alternative medicine use amongst Malaysian orthopaedic oncology patients. BMC Complement Altern Med (2014) 0.82

Support service use and interest in support services among lung cancer patients. Lung Cancer (2013) 0.82

Exploring Willingness to Participate in Clinical Trials by Ethnicity. J Racial Ethn Health Disparities (2016) 0.81

Understanding the role of scientific evidence in consumer evaluation of natural health products for osteoarthritis an application of the means end chain approach. BMC Complement Altern Med (2012) 0.81

Complementary and alternative medicine use and its association with quality of life among Lebanese breast cancer patients: a cross-sectional study. BMC Complement Altern Med (2015) 0.81

Corporate culture assessments in integrative oncology: a qualitative case study of two integrative oncology centers. Evid Based Complement Alternat Med (2013) 0.81

A complex nursing intervention of complementary and alternative medicine (CAM) to increase quality of life in patients with breast and gynecologic cancer undergoing chemotherapy: study protocol for a partially randomized patient preference trial. Trials (2015) 0.80

Quality of Life in CAM and Non-CAM Users among Breast Cancer Patients during Chemotherapy in Malaysia. PLoS One (2015) 0.80

Potential interactions of complementary and alternative medicine with cancer therapy in outpatients with gynecological cancer in a comprehensive cancer center. J Cancer Res Clin Oncol (2012) 0.80

Adverse Drug Reactions and Expected Effects to Therapy with Subcutaneous Mistletoe Extracts (Viscum album L.) in Cancer Patients. Evid Based Complement Alternat Med (2014) 0.80

Natural products and complementary therapies for chemotherapy-induced peripheral neuropathy: A systematic review. Crit Rev Oncol Hematol (2015) 0.80

Integrative Oncology Physician Consultations at a Comprehensive Cancer Center: Analysis of Demographic, Clinical and Patient Reported Outcomes. J Cancer (2017) 0.79

Bridging cross-cultural gaps: monitoring herbal use during chemotherapy in patients referred to integrative medicine consultation in Israel. Support Care Cancer (2014) 0.79

Understanding CAM Natural Health Products: Implications of Use Among Cancer Patients and Survivors. J Adv Pract Oncol (2013) 0.79

Complementary and Alternative Medicine Use and Its Association with Quality of Life among Cancer Patients Receiving Chemotherapy in Ethiopia: A Cross-Sectional Study. Evid Based Complement Alternat Med (2016) 0.78

Cancer survivors' disclosure of complementary health approaches to physicians: the role of patient-centered communication. Cancer (2014) 0.78

The Use of Complementary and Alternative Medicine among Lebanese Adults: Results from a National Survey. Evid Based Complement Alternat Med (2015) 0.78

Integrative oncology. Evid Based Complement Alternat Med (2013) 0.78

Complementary and Integrative Health Practices Among Hispanics Diagnosed with Colorectal Cancer: Utilization and Communication with Physicians. J Altern Complement Med (2016) 0.78

Aqueous extract of Polygonum bistorta modulates proteostasis by ROS-induced ER stress in human hepatoma cells. Sci Rep (2017) 0.78

A consultation training program for physicians for communication about complementary medicine with breast cancer patients: a prospective, multi-center, cluster-randomized, mixed-method pilot study. BMC Cancer (2016) 0.77

Wishes and beliefs of cancer patients regarding counseling on integrative medicine. Breast Care (Basel) (2014) 0.77

Herbal medicine use by surgery patients in Hungary: a descriptive study. BMC Complement Altern Med (2015) 0.77

Yoga in adult cancer: an exploratory, qualitative analysis of the patient experience. BMC Complement Altern Med (2015) 0.77

Yoga in adult cancer: a pilot survey of attitudes and beliefs among oncologists. Curr Oncol (2015) 0.77

A survey investigating the associations between self-management practices and quality of life in cancer survivors. Support Care Cancer (2015) 0.77

Use of complementary and alternative medicine before and after organ removal due to urologic cancer. Patient Prefer Adherence (2015) 0.77

Commonly used methods of complementary medicine in the treatment of breast cancer. Breast Care (Basel) (2013) 0.77

Improving Patient-Centered Care: A Cross-Sectional Survey of Prior Use and Interest in Complementary and Integrative Health Approaches Among Hospitalized Oncology Patients. J Altern Complement Med (2015) 0.76

Health services research of integrative oncology in palliative care of patients with advanced pancreatic cancer. BMC Cancer (2016) 0.76

Decreased Cortisol and Pain in Breast Cancer: Biofield Therapy Potential. Evid Based Complement Alternat Med (2015) 0.76

Yoga for Health-Related Quality of Life in Adult Cancer: A Randomized Controlled Feasibility Study. Evid Based Complement Alternat Med (2015) 0.76

Development and Validation of a Standardized Questionnaire and Standardized Diary for Use in Integrative Medicine Consultations in Gynecologic Oncology. Geburtshilfe Frauenheilkd (2015) 0.76

Complementary and alternative medicine for cancer patients: results of the EPAAC survey on integrative oncology centres in Europe. Support Care Cancer (2014) 0.76

Development and Validation of an Instrument for Measuring Attitudes and Beliefs about Complementary and Alternative Medicine (CAM) Use among Cancer Patients. Evid Based Complement Alternat Med (2012) 0.76

Use of Complementary and Alternative Medicine (CAM) as Part of the Oncological Treatment: Survey about Patients' Attitude towards CAM in a University-Based Oncology Center in Germany. PLoS One (2016) 0.75

The influence of chlorella and its hot water extract supplementation on quality of life in patients with breast cancer. Evid Based Complement Alternat Med (2014) 0.75

Prevalence and Perspectives of Complementary and Alternative Medicine among University Students in Atlanta, Newcastle upon Tyne, and New Delhi. Int Sch Res Notices (2016) 0.75

Epidemiology of complementary and alternative medicine therapy use in allogeneic hematopoietic stem cell transplant survivorship patients in Australia. Cancer Med (2016) 0.75

Mapping the risk perception and communication gap between different professions of healthcare providers in cancer care: a cross-sectional protocol. BMJ Open (2015) 0.75

What Everybody is Doing but No One is Talking About: Use of Complementary and Alternative Medicine in the ANCA Associated Vasculitis Population. J Autoimmune Dis Rheumatol (2014) 0.75

Complementary and alternative medicine (CAM) as part of primary health care in Germany-comparison of patients consulting general practitioners and CAM practitioners: a cross-sectional study. BMC Complement Altern Med (2016) 0.75

The Clinical Effects of Aromatherapy Massage on Reducing Pain for the Cancer Patients: Meta-Analysis of Randomized Controlled Trials. Evid Based Complement Alternat Med (2016) 0.75

Missed Opportunities: A Mixed-Methods Analysis of CAM Discussions and Practices in the Management of Pain in Oncology. J Pain Symptom Manage (2016) 0.75

Complementary and alternative medicine: attitudes, knowledge and use among surgeons and anaesthesiologists in Hungary. BMC Complement Altern Med (2016) 0.75

Sulforaphane inhibits proliferation and invasive activity of everolimus-resistant kidney cancer cells in vitro. Oncotarget (2016) 0.75

Increases in Xu Zheng and Yu Zheng among Patients with Breast Cancer Receiving Different Anticancer Drug Therapies. Evid Based Complement Alternat Med (2013) 0.75

Integration of complementary medicine in supportive cancer care: survey of health-care providers' perspectives from 16 countries in the Middle East. Support Care Cancer (2015) 0.75

Integrative Medicine in Head and Neck Cancer. Otolaryngol Head Neck Surg (2016) 0.75

Gynecologic oncologists' attitudes and practices relating to integrative medicine: results of a nationwide AGO survey. Arch Gynecol Obstet (2017) 0.75

Developing and implementing a complex Complementary and Alternative (CAM) nursing intervention for breast and gynecologic cancer patients undergoing chemotherapy-report from the CONGO (complementary nursing in gynecologic oncology) study. Support Care Cancer (2015) 0.75

Integrative Oncology Outpatient Consultations: Long-Term Effects on Patient-Reported Symptoms and Quality of Life. J Cancer (2017) 0.75

Use of non-conventional medicine two years after cancer diagnosis in France: evidence from the VICAN survey. J Cancer Surviv (2017) 0.75

Complementary and Integrative Medicine in Hematologic Malignancies: Questions and Challenges. Curr Oncol Rep (2017) 0.75

Articles by these authors

Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet (2008) 20.62

Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. AIDS (2009) 11.62

Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet (2004) 8.77

Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials. Lancet (2009) 6.92

Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet (2007) 6.77

A systematic review of the 5-year survival and complication rates of implant-supported single crowns. Clin Oral Implants Res (2007) 3.82

Childhood cancer and nuclear power plants in Switzerland: a census-based cohort study. Int J Epidemiol (2011) 2.93

Domains of physical activity and all-cause mortality: systematic review and dose-response meta-analysis of cohort studies. Int J Epidemiol (2011) 2.83

Women's perception of the benefits of mammography screening: population-based survey in four countries. Int J Epidemiol (2003) 2.79

A systematic review of the survival and complication rates of fixed partial dentures (FPDs) after an observation period of at least 5 years. II. Combined tooth--implant-supported FPDs. Clin Oral Implants Res (2004) 2.57

Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in nine industrialized countries. Int J Epidemiol (2009) 2.51

Duration from seroconversion to eligibility for antiretroviral therapy and from ART eligibility to death in adult HIV-infected patients from low and middle-income countries: collaborative analysis of prospective studies. Sex Transm Infect (2008) 2.49

Religion and assisted and non-assisted suicide in Switzerland: National Cohort Study. Int J Epidemiol (2010) 2.49

A systematic review of the survival and complication rates of resin-bonded bridges after an observation period of at least 5 years. Clin Oral Implants Res (2007) 2.24

Association of 1,5-anhydroglucitol and 2-h postprandial blood glucose in type 2 diabetic patients. Diabetes Care (2008) 2.22

Selenium for preventing cancer. Cochrane Database Syst Rev (2011) 2.11

A systematic review of the success of sinus floor elevation and survival of implants inserted in combination with sinus floor elevation. J Clin Periodontol (2008) 2.09

Escalating incidence of eosinophilic esophagitis: a 20-year prospective, population-based study in Olten County, Switzerland. J Allergy Clin Immunol (2011) 2.07

Surgical glove perforation and the risk of surgical site infection. Arch Surg (2009) 2.04

A systematic review of the survival and complication rates of fixed partial dentures (FPDs) after an observation period of at least 5 years. Clin Oral Implants Res (2004) 2.03

Comparison of survival and complication rates of tooth-supported fixed dental prostheses (FDPs) and implant-supported FDPs and single crowns (SCs). Clin Oral Implants Res (2007) 1.93

Clinical efficacy of antiretroviral combination therapy based on protease inhibitors or non-nucleoside analogue reverse transcriptase inhibitors: indirect comparison of controlled trials. BMJ (2004) 1.93

Incident cancer burden attributable to excess body mass index in 30 European countries. Int J Cancer (2010) 1.93

All cause mortality in the Swiss HIV Cohort Study from 1990 to 2001 in comparison with the Swiss population. AIDS (2004) 1.91

Intravaginal practices, bacterial vaginosis, and HIV infection in women: individual participant data meta-analysis. PLoS Med (2011) 1.89

Background ionizing radiation and the risk of childhood cancer: a census-based nationwide cohort study. Environ Health Perspect (2015) 1.88

The timing of surgical antimicrobial prophylaxis. Ann Surg (2008) 1.85

Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice. 4-year results from a large 2-institutional cohort study. J Am Coll Cardiol (2008) 1.84

A systematic review of the survival and complication rates of all-ceramic and metal-ceramic reconstructions after an observation period of at least 3 years. Part II: Fixed dental prostheses. Clin Oral Implants Res (2007) 1.82

A systematic review of the survival and complication rates of fixed partial dentures (FPDs) after an observation period of at least 5 years. Clin Oral Implants Res (2004) 1.80

Family satisfaction in the intensive care unit: what makes the difference? Intensive Care Med (2009) 1.79

Treatment response of cystic echinococcosis to benzimidazoles: a systematic review. PLoS Negl Trop Dis (2009) 1.77

A systematic review of the survival and complication rates of implant supported fixed dental prostheses with cantilever extensions after an observation period of at least 5 years. Clin Oral Implants Res (2009) 1.77

Body mass index, hormone replacement therapy, and endometrial cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev (2010) 1.75

Incidence and predictors of atrioventricular conduction impairment after transcatheter aortic valve implantation. Am J Cardiol (2010) 1.71

The association of biomass fuel combustion on pulmonary function tests in the adult population of Mid-Anatolia. Soz Praventivmed (2004) 1.65

Chlamydia infection, pelvic inflammatory disease, ectopic pregnancy and infertility: cross-national study. Sex Transm Infect (2011) 1.65

Cohort Profile: the Swiss National Cohort--a longitudinal study of 6.8 million people. Int J Epidemiol (2008) 1.64

Quality of reporting of clinical studies to assess and compare performance of implant-supported restorations. J Clin Periodontol (2012) 1.62

A systematic review of the survival and complication rates of implant-supported fixed dental prostheses (FDPs) after a mean observation period of at least 5 years. Clin Oral Implants Res (2012) 1.60

A systematic review of the performance of ceramic and metal implant abutments supporting fixed implant reconstructions. Clin Oral Implants Res (2009) 1.60

Systematic review of the survival rate and the incidence of biological, technical, and aesthetic complications of single crowns on implants reported in longitudinal studies with a mean follow-up of 5 years. Clin Oral Implants Res (2012) 1.52

Suicide assisted by right-to-die associations: a population based cohort study. Int J Epidemiol (2014) 1.48

What is the optimal number of implants for removable reconstructions? A systematic review on implant-supported overdentures. Clin Oral Implants Res (2012) 1.47

A systematic review of the survival and complication rates of all-ceramic and metal-ceramic reconstructions after an observation period of at least 3 years. Part I: Single crowns. Clin Oral Implants Res (2007) 1.42

A systematic review of the success of sinus floor elevation and survival of implants inserted in combination with sinus floor elevation. Part II: transalveolar technique. J Clin Periodontol (2008) 1.40

Survival and failure rates of orthodontic temporary anchorage devices: a systematic review. Clin Oral Implants Res (2009) 1.39

A systematic review on the accuracy and the clinical outcome of computer-guided template-based implant dentistry. Clin Oral Implants Res (2009) 1.34

A Swiss neighbourhood index of socioeconomic position: development and association with mortality. J Epidemiol Community Health (2012) 1.30

Childhood leukaemia and socioeconomic status: what is the evidence? Radiat Prot Dosimetry (2008) 1.29

Cohort Profile: the Swiss Hepatitis C Cohort Study (SCCS). Int J Epidemiol (2007) 1.28

A systematic review assessing soft tissue augmentation techniques. Clin Oral Implants Res (2009) 1.28

Erythropoietin or Darbepoetin for patients with cancer--meta-analysis based on individual patient data. Cochrane Database Syst Rev (2009) 1.26

Influence of residual pockets on progression of periodontitis and tooth loss: results after 11 years of maintenance. J Clin Periodontol (2008) 1.23

Educational inequalities in life expectancy in German speaking part of Switzerland 1990-1997: Swiss National Cohort. Swiss Med Wkly (2006) 1.19

Impact of unlinked deaths and coding changes on mortality trends in the Swiss National Cohort. BMC Med Inform Decis Mak (2013) 1.18

The Swiss Childhood Cancer Registry: rationale, organisation and results for the years 2001-2005. Swiss Med Wkly (2007) 1.17

The Swiss National Cohort: a unique database for national and international researchers. Int J Public Health (2010) 1.17

Selenium for preventing cancer. Cochrane Database Syst Rev (2014) 1.17

Euthanasia and assisted suicide in selected European countries and US states: systematic literature review. Med Care (2013) 1.15

Association between reported exposure to road traffic and respiratory symptoms in children: evidence of bias. Int J Epidemiol (2006) 1.14

Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile neutropenia in breast cancer patients. Cochrane Database Syst Rev (2012) 1.14

Tuberculosis and the risk of opportunistic infections and cancers in HIV-infected patients starting ART in Southern Africa. Trop Med Int Health (2012) 1.12

Occurrence, risk factors, diagnosis and treatment of syphilis in the prospective observational Swiss HIV Cohort Study. AIDS (2010) 1.11

Predictors of readmission and health related quality of life in patients with chronic heart failure: a comparison of different psychosocial aspects. J Behav Med (2010) 1.11

Unprotected left main stenting in the real world: two-year outcomes of the French left main taxus registry. Circulation (2009) 1.11

Mycobacterium tuberculosis transmission in a country with low tuberculosis incidence: role of immigration and HIV infection. J Clin Microbiol (2011) 1.10

Effect of mutation and genetic background on drug resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother (2012) 1.09

Helicobacter pylori infection and colorectal cancer risk: a meta-analysis. Helicobacter (2006) 1.09

Epidemiology of pulmonary hypertension: new data from the Swiss registry. Swiss Med Wkly (2008) 1.06

Meta-analysis and dose-response metaregression: circulating insulin-like growth factor I (IGF-I) and mortality. J Clin Endocrinol Metab (2011) 1.06

Computer technology applications in surgical implant dentistry: a systematic review. Int J Oral Maxillofac Implants (2009) 1.05

Ante's (1926) law revisited: a systematic review on survival rates and complications of fixed dental prostheses (FDPs) on severely reduced periodontal tissue support. Clin Oral Implants Res (2007) 1.05

HIV infection disrupts the sympatric host-pathogen relationship in human tuberculosis. PLoS Genet (2013) 1.04

Swiss primary care physicians' knowledge, attitudes and perception towards genetic testing for hereditary breast cancer. Fam Cancer (2003) 1.03

Economic burden of surgical site infections at a European university hospital. Infect Control Hosp Epidemiol (2008) 1.00

Long-term cardiovascular and non-cardiovascular mortality in women and men with type 1 and type 2 diabetes mellitus: a 30-year follow-up in Switzerland. Swiss Med Wkly (2009) 0.98

The impact of anemia on long-term clinical outcome in patients undergoing revascularization with the unrestricted use of drug-eluting stents. Circ Cardiovasc Interv (2012) 0.96

Determination of the prevalence of infection with Mycobacterium tuberculosis among persons vaccinated against Bacillus Calmette-Guérin in South Korea. Am J Epidemiol (2002) 0.96

Influenza-attributable mortality among the elderly in Switzerland. Swiss Med Wkly (2006) 0.95

Cemented and screw-retained implant reconstructions: a systematic review of the survival and complication rates. Clin Oral Implants Res (2012) 0.93

A systematic review of the effects of full-mouth debridement with and without antiseptics in patients with chronic periodontitis. J Clin Periodontol (2008) 0.91

Improvements in implant dentistry over the last decade: comparison of survival and complication rates in older and newer publications. Int J Oral Maxillofac Implants (2014) 0.91

Prevention and control of surgical site infections: review of the Basel Cohort Study. Swiss Med Wkly (2012) 0.91

Glucocorticoid replacement and mortality in patients with nonfunctioning pituitary adenoma. J Clin Endocrinol Metab (2012) 0.90

Serologic vaccination response after solid organ transplantation: a systematic review. PLoS One (2013) 0.89

The association of preoperative anemia and perioperative allogeneic blood transfusion with the risk of surgical site infection. Transfusion (2009) 0.89

IGF-I, IGF binding protein-3 and breast cancer risk: comparison of 3 meta-analyses. Int J Cancer (2005) 0.89

What is the optimal number of implants for fixed reconstructions: a systematic review. Clin Oral Implants Res (2012) 0.87

Growth hormone receptor polymorphism and growth hormone therapy response in children: a Bayesian meta-analysis. Am J Epidemiol (2012) 0.86

National laboratory reports of Chlamydia trachomatis seriously underestimate the frequency of genital chlamydial infections among women in Switzerland. Sex Transm Dis (2002) 0.86

Antiplatelets versus anticoagulants for the treatment of cervical artery dissection: Bayesian meta-analysis. PLoS One (2013) 0.86

Differences across health care systems in outcome and cost-utility of surgical and conservative treatment of chronic low back pain: a study protocol. BMC Musculoskelet Disord (2008) 0.86

Re: body mass index and risk of lung cancer among never, former, and current smokers. J Natl Cancer Inst (2012) 0.85

Online survey of cancer patients on complementary and alternative medicine. Oncol Res Treat (2014) 0.85

Daily physical activities and sports in adult survivors of childhood cancer and healthy controls: a population-based questionnaire survey. PLoS One (2012) 0.85

Peri-implantitis susceptibility as it relates to periodontal therapy and supportive care. Clin Oral Implants Res (2012) 0.85

Incidence and risk factors of homicide-suicide in Swiss households: National Cohort study. PLoS One (2013) 0.84

Maxillary sinus floor elevation using the (transalveolar) osteotome technique with or without grafting material. Part I: Implant survival and patients' perception. Clin Oral Implants Res (2009) 0.84